Screener
Tarsus Pharmaceuticals, Inc. TARS Operating lease modification
Operating lease modification at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:LeaseModificationExpenseNonCash.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-K, filed February 23, 2026. Open the filing →
- Filed
- Feb 23, 2026, 4:11 PM EST
- Fiscal year
- FY2025
- Accession
- 0001819790-26-000019
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s operating lease modification?
- Tarsus Pharmaceuticals, Inc. (TARS) reported operating lease modification of $0 in Q4 2025.
- How has Tarsus Pharmaceuticals, Inc.'s operating lease modification changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s operating lease modification decreased by 100.0% year-over-year, from $269.5K to $0.
- What does operating lease modification mean?
- Operating lease modification as reported by Tarsus Pharmaceuticals, Inc. Common Stock.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s operating lease modification.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude